Description
SKIN1004 Madagascar Centella Poremizing Light Gel Cream 75ml is a gentle yet powerful skincare solution specifically formulated for oily, combination, and sensitive skin types. Designed to target enlarged pores and uneven skin texture, this lightweight gel cream combines advanced Korean skincare science with natural, skin-loving ingredients.
At the heart of the formula is Madagascar Centella Asiatica, known for its exceptional calming and healing properties. This potent botanical extract helps reduce redness, irritation, and inflammation, making it ideal for sensitive or acne-prone skin. It also supports skin regeneration and strengthens the skin barrier, promoting a healthier, more resilient complexion.
The formula is further enhanced with Himalayan pink salt, a natural exfoliant and detoxifying ingredient rich in minerals. It works to deeply cleanse the pores, removing impurities, excess oil, and buildup that can lead to blackheads and breakouts. The result is visibly refined pores and a smoother skin texture over time.
Niacinamide (Vitamin B3) is included to brighten dull skin, fade dark spots, and regulate sebum production. This multitasking ingredient improves skin tone while helping to prevent future breakouts. Adenosine adds anti-aging benefits by smoothing fine lines and improving skin elasticity.
The gel texture is fast-absorbing and non-sticky, delivering long-lasting hydration without clogging pores. It leaves the skin feeling fresh, clean, and balanced with a soft matte finish — making it a great choice for hot, humid climates or those with oily T-zones.
Whether used as part of your day or night routine, SKIN1004 Poremizing Light Gel Cream offers a refreshing burst of hydration while addressing multiple skin concerns in one simple step. It’s free from parabens, artificial fragrances, alcohol, and non-comedogenic, making it safe for daily use on even the most reactive skin.
Give your skin a calming reset and a pore-perfecting boost with this Korean skincare essential.
Reviews
There are no reviews yet.